April 1, 2025The Egyptian Journal of Haematology

Clinicopathological characteristics and outcome of patients with Philadelphia negative myeloproliferative neoplasms: first report from Upper Egypt

View Full Paper

Ask AI

Bookmark

Survival rates were 95.8% in polycythemia vera, 62.5% in primary myelofibrosis, and 100% in essential thrombocythemia patients.
Patients with primary myelofibrosis showed more severe symptoms like fatigue, fever, and splenic enlargement.
This prospective study included 98 patients with Philadelphia chromosome-negative myeloproliferative neoplasms over 2 years.
Poor outcomes suggest significant health impacts and need for improved management in these patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Observational analysis highlights poor outcomes in patients with Philadelphia chromosome-negative myeloproliferative neoplasms, indicating a severe disease burden.

Cite This Study

Khaled et al. (2025) studied this question.

synapsesocial.com/papers/68af6d847567bf4f94fea6c2 https://doi.org/10.4103/ejh.ejh_19_25

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis highlights poor outcomes in patients with Philadelphia chromosome-negative myeloproliferative neoplasms, indicating a severe disease burden.

Clinicopathological characteristics and outcome of patients with Philadelphia negative myeloproliferative neoplasms: first report from Upper Egypt

Key Points

Discussion

Implication

Cite This Study

Clinicopathological characteristics and outcome of patients with Philadelphia negative myeloproliferative neoplasms: first report from Upper Egypt

Key Points

Discussion

Implication

Cite This Study